Wide Ranks

COR

Cencora, Inc.

249.69

Top Statistics
Market Cap 48 B Forward PE 15.30 Revenue Growth 14.70 %
Current Ratio 0.88 Trailing PE 33.12 Earnings Growth -99.00 %
Profit Margins 0.51 % Peg Ratio Dividend Yield 0.88 %
Enterprice / EBITA 11.68 Enterprise / Revenue 0.1710 Price To Sales Trailing12 Months 0.1642
Profitability
Profit Margins 0.51 % Operating Margins 0.85 %
Balance Sheet
Total Cash 3 B Total Cash Per Share 15.96 Total Debt 4 B
Total Debt To Equity 557.75 Current Ratio 0.88 Book Value Per Share 4.01
All Measures
Short Ratio 730.00 % Message Board Id finmb_24809 Shares Short Prior Month 9 M
Return On Equity 2.09 City Conshohocken Uuid e928eee5-ddbc-3bf9-88a8-7749f9365980
Previous Close 248.45 First Trade Date Epoch Utc 797 M Book Value 4.01
Beta 0.4360 Total Debt 4 B Volume 903540
Price To Book 62.30 Last Split Date 1 B Fifty Two Week Low 195.83
Total Cash Per Share 15.96 Total Revenue 293 B Shares Short Previous Month Date 1 B
Target Median Price 270.00 Max Age 86400 Recommendation Mean 2.06
Sand P52 Week Change 0.3133 Operating Margins 0.85 % Last Dividend Value 0.5500
Target Mean Price 267.32 Net Income To Common 1 B Ask 251.50
Short Percent Of Float 0.0691 Implied Shares Outstanding 198 M Last Fiscal Year End 1 B
Trailing Peg Ratio 128.65 % Average Daily Volume10 Day 1 M Average Volume10days 1 M
Total Cash 3 B Next Fiscal Year End 1 B Revenue Per Share 1480.88
Held Percent Insiders 0.1071 Ebitda Margins 1.46 % Dividend Rate 2.20
Trailing PE 33.12 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 248.45 Target Low Price 230.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 233.99 Open 246.54 Dividend Yield 0.88 %
State PA Free Cashflow 3 B Return On Assets 0.0310
Time Zone Short Name EST Trailing Eps 7.54 Day Low 246.54
Address1 1 West First Avenue Trailing Annual Dividend Rate 2.04 Price Hint 2
Shares Outstanding 193 M Target High Price 292.00 Website https://www.cencora.com
52 Week Change 0.2278 Average Volume 1 M Earnings Quarterly Growth -99.00 %
Forward Eps 16.36 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 49.80 % Last Split Factor 2:1 Regular Market Day High 251.49
Is_sp_500 True Profit Margins 0.51 % Debt To Equity 557.75
Fifty Two Week High 251.56 Day High 251.49 Shares Short 9 M
Regular Market Open 246.54 Industry Key medical-distribution Bid 222.22
Earnings Growth -99.00 % Enterprise To Revenue 0.1710 Revenue Growth 14.70 %
Shares Percent Shares Out 0.0510 Operating Cashflow 3 B Five Year Avg Dividend Yield 131.00 %
Currency USD Market Cap 48 B Time Zone Full Name America/New_York
Is_nasdaq_100 False Zip 19428-1800 Payout Ratio 27.09 %
Quote Type EQUITY Industry Medical Distribution Ex Dividend Date 1 B
Regular Market Day Low 246.54 Held Percent Institutions 0.9370 Long Name Cencora, Inc.
Current Price 249.69 Enterprise To Ebitda 11.68 Financial Currency USD
Trailing Annual Dividend Yield 0.82 % Current Ratio 0.88 Gross Margins 3.39 %
Industry Disp Medical Distribution Number Of Analyst Opinions 16 Country United States
Float Shares 175 M Two Hundred Day Average 233.54 Ir Website http://www.amerisourcebergen.com/investor/phoenix.zhtml?c=61181&p=irol-irhome
Enterprise Value 50 B Price To Sales Trailing12 Months 0.1642 Forward PE 15.30
Regular Market Volume 903540 Last Dividend Date 1 B Ebitda 4 B
Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.

The company's U.

S.

Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.

This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.

Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry.

The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023.

Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.